tiprankstipranks
Advertisement
Advertisement
Aldeyra Therapeutics Faces Securities Lawsuit Over Reproxalap Trial Disclosures 
PremiumClass ActionAldeyra Therapeutics Faces Securities Lawsuit Over Reproxalap Trial Disclosures 
3M ago
Aldeyra Therapeutics Announces Upcoming Board Member Departure
Premium
Company Announcements
Aldeyra Therapeutics Announces Upcoming Board Member Departure
3M ago
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
Premium
Class Action
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
4M ago
Morning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up 3/17/26: Today’s Biggest Stock Market Stories!
5M ago
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
Premium
The Fly
FDA issues Aldeyra CRL saying reproxalap NDA failed to demonstrate efficacy
5M ago
How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
Premium
Market News
How Did the FDA Shatter Investor Confidence In Aldeyra Therapeutics Stock (ALDX) Today?
5M ago
Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
PremiumThe FlyMidday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
8M ago
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
Premium
Ratings
Buy Rating for Aldeyra Therapeutics: Confidence in Reproxalap’s Approval and Financial Upside
8M ago
Unusually active option classes on open December 16th
Premium
The Fly
Unusually active option classes on open December 16th
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100